Financials
Financial year 2025
Worth noting
- More debts than assets in the latest financial year.
- Little cash and receivables against the short-term debts.
Gross margin
€ 5,783
▲ 151% vs 2024
Profit
Growing€ 1,861
▲ 203% vs 2024
Debts
High€ 24,489
▼ 49% vs 2024
CROIXSSANCE PHARMA from Zaventem, company number BE0644605976, closed financial year 2025 with a result of € 1,861 after tax. For that financial year CROIXSSANCE PHARMA recorded a gross margin of € 5,783 and equity of € -15,015. Compared with financial year 2024, the result moved from € -1,801 to € 1,861. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.
What happened at CROIXSSANCE PHARMA?
What happened at CROIXSSANCE PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 1,861. Source: NBB ↗
- New establishment in Sint-Pieters-Woluwe. KBO
- Start of the company according to the CBE. KBO
In short
From € 7,459 profit in 2021 to € 1,861 profit in 2025.
Paid € 1,507 in corporate taxes since 2021.
Best year ever: 2021, with € 7,459 profit.
A new publication or filing at CROIXSSANCE PHARMA? We notify you, reason included.
Follow CROIXSSANCE PHARMANeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind CROIXSSANCE PHARMA is Alfred DANNOURA. Alfred DANNOURA is also behind SagaCité.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Kouterlaan 99
1930 Zaventem
Jean-Baptiste Dumoulinstraat 52
1150 Sint-Pieters-Woluwe
Active since 17 December 2015
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0644.605.976
- VAT number
- BE 0644.605.976
- Registered office
- Kouterlaan 99, 1930 Zaventem
- Names & denominations
- CROIXSSANCE PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 December 2015
- Peppol
- Active · Active since 17 Jun 2024
- Activities · NACE
Detailhandel in farmaceutische producten